FDA Inspection 1243498 — Nexair, LLC

Nexair, LLC — FEI 1015040

The FDA completed an inspection of Nexair, LLC on Jul 11, 2024 in Jacksonville, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 11, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Jacksonville, FL (United States)

Citations

IDCFRDescription
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
356521 CFR 211.58Buildings not maintained in good state of repair